These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 31129275)
1. FOXE1 inhibits cell proliferation, migration and invasion of papillary thyroid cancer by regulating PDGFA. Ding Z; Ke R; Zhang Y; Fan Y; Fan J Mol Cell Endocrinol; 2019 Aug; 493():110420. PubMed ID: 31129275 [TBL] [Abstract][Full Text] [Related]
2. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway. Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-524-5p suppresses the progression of papillary thyroid carcinoma cells via targeting on FOXE1 and ITGA3 in cell autophagy and cycling pathways. Liu H; Chen X; Lin T; Chen X; Yan J; Jiang S J Cell Physiol; 2019 Aug; 234(10):18382-18391. PubMed ID: 30941771 [TBL] [Abstract][Full Text] [Related]
4. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p. Wang D; Zheng Y Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression. Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471 [TBL] [Abstract][Full Text] [Related]
6. Wen J; Lin B; Lin L; Chen Y; Wang O Aging (Albany NY); 2020 Aug; 12(16):16437-16456. PubMed ID: 32857728 [TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of FOXE1 in papillary thyroid carcinoma. Fan Y; Ding Z; Yang Z; Deng X; Kang J; Wu B; Zheng Q Mol Med Rep; 2013 Jul; 8(1):123-7. PubMed ID: 23715628 [TBL] [Abstract][Full Text] [Related]
8. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression. Cai X; Zhao Z; Dong J; Lv Q; Yun B; Liu J; Shen Y; Kang J; Li J Cell Death Dis; 2019 Feb; 10(3):184. PubMed ID: 30796202 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-519d-3p is Associated with Poor Outcomes and Facilitates Tumor Progression in Papillary Thyroid Cancer by Regulating FOXQ1. Li P; Pan X; Zheng Z; Sun Y; Han Y; Dong J; Lu M Horm Metab Res; 2021 Sep; 53(9):625-632. PubMed ID: 34496413 [TBL] [Abstract][Full Text] [Related]
10. ciRS-7 Promotes the Proliferation and Migration of Papillary Thyroid Cancer by Negatively Regulating the miR-7/Epidermal Growth Factor Receptor Axis. Han JY; Guo S; Wei N; Xue R; Li W; Dong G; Li J; Tian X; Chen C; Qiu S; Wang T; Xiao Q; Liu C; Xu J; Chen KS Biomed Res Int; 2020; 2020():9875636. PubMed ID: 32685551 [TBL] [Abstract][Full Text] [Related]
11. MiR-146b-5p Regulates the Expression of Long Noncoding RNA Peng Y; Fang X; Yao H; Zhang Y; Shi J Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601 [No Abstract] [Full Text] [Related]
12. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma. Zhang Z; Li SY; Zhang LB Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway. Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134 [TBL] [Abstract][Full Text] [Related]
14. BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability. Zhao M; Yang F; Sang C; Yan C; Wang Z J Endocrinol Invest; 2021 Oct; 44(10):2165-2174. PubMed ID: 33543443 [TBL] [Abstract][Full Text] [Related]
15. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637. Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928 [TBL] [Abstract][Full Text] [Related]
16. MiR-200c promotes papillary thyroid cancer cell proliferation, migration, and invasion by downregulating PTEN. Guo K; Wang J; Shu L; Zhou G Tissue Cell; 2021 Dec; 73():101647. PubMed ID: 34543800 [TBL] [Abstract][Full Text] [Related]
17. CXCR4 promotes migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma by activating STAT3 signaling pathway. Hu Y; Xu Z; Zhou D; Hou H; Liu B; Long H; Hu W; Tang Y; Wang J; Wei D; Zhao Q J Cancer Res Ther; 2024 Aug; 20(4):1241-1250. PubMed ID: 39206986 [TBL] [Abstract][Full Text] [Related]
18. Credendino SC; Moccia C; Amendola E; D'Avino G; Di Guida L; Clery E; Greco A; Bellevicine C; Brunetti A; De Felice M; De Vita G Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375029 [TBL] [Abstract][Full Text] [Related]
19. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67. Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096 [TBL] [Abstract][Full Text] [Related]
20. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2. Xue KC; Hu DD; Zhao L; Li N; Shen HY Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]